{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:13:50Z","timestamp":1762607630546,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":100,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004480","name":"Shanxi Province Natural Science Foundation","doi-asserted-by":"publisher","award":["202103021224001"],"award-info":[{"award-number":["202103021224001"]}],"id":[{"id":"10.13039\/501100004480","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.lrr.2025.100510","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T17:12:12Z","timestamp":1744477932000},"page":"100510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Case report: Experience of a rare case of primary acute mast cell leukemia"],"prefix":"10.1016","volume":"23","author":[{"given":"Zhijuan","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanru","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinlei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lrr.2025.100510_bib0001","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.3390\/cancers15061664","article-title":"Mast cell leukemia: an update with a practical review","volume":"15","author":"Zanelli","year":"2023","journal-title":"Cancers. (Basel)"},{"issue":"11","key":"10.1016\/j.lrr.2025.100510_bib0002","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.lrr.2025.100510_bib0003","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/annonc\/mdu047","article-title":"Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal","volume":"25","author":"Valent","year":"2014","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.lrr.2025.100510_bib0004","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/bloodadvances.2022008292","article-title":"Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM registry","volume":"7","author":"Kennedy","year":"2023","journal-title":"Blood Adv."},{"issue":"7","key":"10.1016\/j.lrr.2025.100510_bib0005","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.lrr.2025.100510_bib0006","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000504099","article-title":"The spectrum of aggressive mastocytosis: a workshop report and literature review","volume":"87","author":"Leguit","year":"2020","journal-title":"Pathobiology"},{"key":"10.1016\/j.lrr.2025.100510_bib0007","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.leukres.2017.05.018","article-title":"Mast cell leukemia (MCL): clinico-pathologic and molecular features and survival outcome","volume":"59","author":"Jain","year":"2017","journal-title":"Leuk. Res."},{"issue":"6","key":"10.1016\/j.lrr.2025.100510_bib0008","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3343\/alm.2017.37.6.547","article-title":"Highly aggressive de novo aleukemic variant of mast cell leukemia without KIT D816V mutation","volume":"37","author":"Suh","year":"2017","journal-title":"Ann. Lab. Med."},{"issue":"7","key":"10.1016\/j.lrr.2025.100510_bib0009","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/dc.23965","article-title":"Acute mast cell leukemia: a rare but highly aggressive hematopoietic neoplasm","volume":"46","author":"Costopoulos","year":"2018","journal-title":"Diagn. Cytopathol."},{"issue":"1","key":"10.1016\/j.lrr.2025.100510_bib0012","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00428-022-03423-3","article-title":"The international consensus classification of mastocytosis and related entities","volume":"482","author":"Leguit","year":"2023","journal-title":"Virchows Arch."},{"issue":"14","key":"10.1016\/j.lrr.2025.100510_bib0013","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.3390\/cancers14143474","article-title":"Systemic mastocytosis and other entities involving mast cells: a practical review and update","volume":"14","author":"El Hussein","year":"2022","journal-title":"Cancers. (Basel)"},{"issue":"12","key":"10.1016\/j.lrr.2025.100510_bib0014","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/s41591-021-01539-8","article-title":"Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial","volume":"27","author":"Gotlib","year":"2021","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.lrr.2025.100510_bib0015","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1038\/s41591-021-01538-9","article-title":"Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial","volume":"27","author":"DeAngelo","year":"2021","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.lrr.2025.100510_bib0016","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1038\/leu.2016.190","article-title":"Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2\/ASXL1\/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis","volume":"30","author":"Jawhar","year":"2016","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.lrr.2025.100510_bib0017","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1158\/1078-0432.CCR-08-0366","article-title":"Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosis","volume":"14","author":"Verstovsek","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.lrr.2025.100510_bib0018","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1365-2362.2008.02036.x","article-title":"Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis","volume":"38","author":"Aichberger","year":"2008","journal-title":"Eur. J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.lrr.2025.100510_bib0019","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1182\/blood-2005-10-3969","article-title":"Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis","volume":"108","author":"Shah","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2025.100510_bib0020","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2147\/CMAR.S363508","article-title":"Acute mast cell leukemia preceded by malignant mediastinal germ cell tumor: a case report and literature review","volume":"14","author":"Wang","year":"2022","journal-title":"Cancer Manage Res."},{"key":"10.1016\/j.lrr.2025.100510_bib0021","article-title":"Myelodysplasia and mast cell leukemia with t(9;22)","volume":"2017","author":"Lago","year":"2017","journal-title":"Case Rep. Oncol. Med."},{"issue":"1","key":"10.1016\/j.lrr.2025.100510_bib0022","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s43162-022-00113-z","article-title":"Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients","volume":"34","author":"Saeed","year":"2022","journal-title":"Egypt. J. Intern. Med."},{"issue":"4","key":"10.1016\/j.lrr.2025.100510_bib0023","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.medcli.2022.06.015","article-title":"Dexamethasone versus weight-adjusted methylprednisolone in patients with moderate-severe SARS-CoV-2 pneumonia","volume":"160","author":"Aomar-Mill\u00e1n","year":"2023","journal-title":"Med. Clin. (Barc)"}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048925000123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048925000123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:08:49Z","timestamp":1762607329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048925000123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":21,"alternative-id":["S2213048925000123"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2025.100510","relation":{},"ISSN":["2213-0489"],"issn-type":[{"type":"print","value":"2213-0489"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Case report: Experience of a rare case of primary acute mast cell leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2025.100510","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100510"}}